V
Valerion Therapeutics, LLC
Valerion Therapeutics is a biotechnology company focused on developing targeted therapies for orphan genetic diseases - Valerion Valerion
About Valerion Therapeutics, LLC
Valerion Therapeutics is a biotechnology company that specializes in developing targeted therapies for orphan genetic diseases, which are rare conditions that affect a small percentage of the population. The company leverages a proprietary antibody-mediated delivery platform to direct therapies to specific tissues through a well-known and extensively studied transport pathway. This platform enhances the intracellular delivery of various therapeutic payloads, such as proteins, drugs, and oligonucleotides, by utilizing a transport mechanism prevalent in muscle and neurons and elevated in certain cancer types.
Valerion's unique approach involves the use of a novel antibody, 3E10, which has cell-penetrating properties dependent on the tissue-localized membrane transporter ENT2. This transporter is naturally enriched in critical organs like the heart and skeletal muscle, allowing Valerion to create targeted fusion and chemical conjugation products. These products offer new treatment options for diseases with limited or no current therapeutic solutions.
Founded in 2007 as 4s3 Bioscience by Dustin Armstrong, Ph.D., and Timothy Harris, Valerion has received early support through peer-reviewed, competitive funding and seed financing from Genzyme Ventures. The company underwent a name change in 2012 and secured a $20 million Series A financing round led by Alopexx, with Genzyme participating on a minority basis.
Valerion operates in the biotechnology sector, primarily serving patients with rare genetic disorders. The company's business model focuses on research and development, partnering with academic institutions and securing funding through grants and investments. Revenue is generated through the development and commercialization of its proprietary therapeutic products.
Source: Dealroom company dataNews
Open roles
Valerion Therapeutics, LLC in the Medford ecosystem
The Valerion Therapeutics, LLC office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Valerion Therapeutics, LLC on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Valerion Therapeutics, LLC on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

